Back to libraryStress & Recovery

Substance P

Research profile · How we handle evidence

Substance P is an endogenous 11-amino-acid neuropeptide of the tachykinin family, first discovered in 1931. It signals primarily through the NK1 receptor and is one of the most-studied neuropeptides in pain (nociception), neurogenic inflammation, mood regulation, and gastrointestinal function.

Evidence Score

42/100

Preclinical signal

Category

Stress & Recovery

Therapeutic area

Standard Dose

Research dosing only (not established for humans)

Research context only

Half-life

-

Plasma elimination

Route

SC

Subcutaneous

Safety Tier

3

Limited data

Overview

Substance P is a natural signaling molecule your nervous system uses to communicate pain and stress-related information, and it's also implicated in mood and nausea/vomiting reflexes (it's the reason NK1-receptor blockers like aprepitant are used as anti-nausea drugs). It's studied as a research reagent, not sold as a self-administration protocol peptide.

Mechanism of Action

Substance P is a natural signaling molecule your nervous system uses to communicate pain and stress-related information, and it's also implicated in mood and nausea/vomiting reflexes (it's the reason NK1-receptor blockers like aprepitant are used as anti-nausea drugs). It's studied as a research reagent, not sold as a self-administration protocol peptide.

NK1 (Neurokinin 1) Receptor AgonismNeurogenic Inflammation SignalingCentral Pain/Nociception Pathway Modulation

Benefits

  • Central research tool for studying pain/nociception pathways
  • Studied in neurogenic inflammation and wound-healing research
  • Studied in mood and stress-response research (NK1 receptor pathway)

Side Effects

  • No established human self-administration safety profile
  • Elevated Substance P/NK1 signaling is associated with pain and inflammatory states in the literature, which informs why it is studied rather than supplemented
  • Effects are highly context- and route-dependent in the animal literature

Contraindications

  • No established human therapeutic use - research reagent only
  • Not evaluated for pregnancy, pediatric, or long-term safety

Structure & Sequence

View 3D structure

Verified structure

Substance P

Sequence illustration backed by PubChem match.

Verified via PubChemMatched by casNumber
C63H98N18O13S1,347.63 DaCAS 33507-63-011 residues
Source: PubChemLookup: 33507-63-0InChIKey ADNPLDHMAVUMIW-CUZNLEPHSA-N
Amino Acid Sequence
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 (RPKPQQFFGLM-NH2)
Molecular Weight
1,347.63 Da
Chemical Formula
C63H98N18O13S
CAS Number
33507-63-0
InChIKey
ADNPLDHMAVUMIW-CUZNLEPHSA-N

Stack & Route Context

Stacks with

No entries listed.

Administration

Subcutaneous

Research Status

Extensively studied endogenous neuropeptide since its 1931 discovery, with a large preclinical literature; human therapeutic development in this space has focused on NK1-receptor antagonist drugs (e.g., aprepitant) rather than Substance P itself.

Approval Status

Preclinical

Sports Legal

Permitted

References

  1. 1

    Biochemistry, Substance P - StatPearls

    2023

    View source

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.